GJIA
FMED icon

Glass Jacobson Investment Advisors’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43K Sell
50
-1,210
-96% -$30.6K ﹤0.01% 562
2026
Q1 		$31K Hold
1,260
– – 0.01% 367
2025
Q4 		$34.1K Buy
1,260
+385
+44% +$10.4K 0.01% 349
2025
Q3 		$21.8K Buy
+875
New +$21.1K 0.01% 389

Other funds holding FMED

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return

Glass Jacobson Investment Advisors's FMED Position: Q2 2026 in Review

Glass Jacobson Investment Advisors reduced its Fidelity Disruptive Medicine ETF (FMED) stake by 96% in Q2 2026, selling an estimated $30.6K and leaving 50 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

Glass Jacobson Investment Advisors first reported a position in FMED in Q3 2025 and has held it in 4 quarters since. The position peaked at $34.1K in Q4 2025. 4 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

  • Glass Jacobson Investment Advisors held 50 shares of Fidelity Disruptive Medicine ETF worth $1.43K as of Q2 2026.
  • Glass Jacobson Investment Advisors sold 1,210 Fidelity Disruptive Medicine ETF shares in Q2 2026, an estimated $30.6K.
  • Fidelity Disruptive Medicine ETF made up ﹤0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #562 holding.
  • Glass Jacobson Investment Advisors first reported a position in Fidelity Disruptive Medicine ETF in Q3 2025 and has held it in 4 quarters since.
  • Glass Jacobson Investment Advisors's Fidelity Disruptive Medicine ETF position peaked at $34.1K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.